<?xml version="1.0" encoding="ISO-8859-1" standalone="yes"?>
<CourseDefinition>
  <Schema>
    <Version>3.0</Version>
    <Date>20120717</Date>
  </Schema>
  <Details>
    <RegimId>NRB-13736</RegimId>
    <Name>Tislelizumab 400mg</Name>
    <ShortName/>
    <MajorVersion>1</MajorVersion>
    <MinorVersion>3</MinorVersion>
    <DefinitionStatus>COMPLETED</DefinitionStatus>
    <PatientMaxSurface/>
    <CourseICDZCode>NONE</CourseICDZCode>
    <CourseAUC>0.00</CourseAUC>
    <MaxAge/>
    <CycleLength>42</CycleLength>
    <ValidForAllDiagnoses/>
    <IsStudyDefinition>NO</IsStudyDefinition>
    <PhysicianComment>Emetogenicitet:Minimal.\n\nKurintervall: 42 dagar.\n\n</PhysicianComment>
    <NurseComment/>
    <PharmacistComment/>
    <PatientComment/>
    <ExternalDocumentation/>
    <ExternalPhysicianDoc>https://kunskapsbanken.cancercentrum.se/redirect/regim/13736</ExternalPhysicianDoc>
    <ExternalNurseDoc>https://kunskapsbanken.cancercentrum.se/redirect/regim/13736</ExternalNurseDoc>
    <ExternalPharmacistDoc/>
    <ExternalPatientDoc/>
    <Rounding/>
    <HasSteps/>
  </Details>
  <Miscellaneous>
    <OriginOfExport>Regimbiblioteket</OriginOfExport>
    <IsAuthorized/>
    <CommittedBy/>
    <CreatedBy/>
    <CreatedDate>20260327</CreatedDate>
  </Miscellaneous>
  <Diagnoses>
    <Diagnose Text="Matstrups- och magsäckscancer"/>
  </Diagnoses>
  <Protocols/>
  <AdditionalInformation/>
  <Days>
    <Day Number="1">
      <Details>
        <Name/>
        <ConfirmationMandatory>NO</ConfirmationMandatory>
        <Comment/>
      </Details>
      <CriticalParameters/>
      <Lines>
        <Line Number="1">
          <Details>
            <Type>FLUID</Type>
            <Route>IVINF</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>0</InfusionMinutes>
            <ProductionBy>WARD</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Fluid Name="Natriumklorid 9 mg/ml">
            <Volume>250</Volume>
            <Steps>0</Steps>
            <Unit>ML</Unit>
            <Calculation/>
          </Fluid>
          <Comments>
            <Comment Text="Spoldropp att fördelas mellan och efter sista läkemedlet"/>
          </Comments>
        </Line>
        <Line Number="2">
          <Details>
            <Type>ANTIDOTE</Type>
            <Route>PO</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>0</InfusionMinutes>
            <ProductionBy>WARD</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Substance Name="Antiemetika">
            <Dose Max="">0</Dose>
            <Unit>MG</Unit>
            <Calculation>STANDARD</Calculation>
          </Substance>
          <Fluid Name="Ej aktuellt">
            <Volume/>
            <Unit/>
            <Calculation/>
          </Fluid>
          <Comments>
            <Comment Text="Tablett/Injektion Antiemetika"/>
            <Comment Text="Ej rutinmässigt p.g.a. minimal emetogen effekt av ingående läkemedel."/>
          </Comments>
        </Line>
        <Line Number="3">
          <Details>
            <Type>SUBSTANCE</Type>
            <Route>IVINF</Route>
            <InfusionHours>0</InfusionHours>
            <InfusionMinutes>30</InfusionMinutes>
            <ProductionBy>PHARMACY</ProductionBy>
            <RelationType>NONE</RelationType>
          </Details>
          <Substance Name="tislelizumab">
            <Dose Max="">400</Dose>
            <Steps>0</Steps>
            <Unit>MG</Unit>
            <Calculation>STANDARD</Calculation>
          </Substance>
          <Fluid Name="Natriumklorid 9 mg/ml">
            <Volume>100</Volume>
            <Steps>0</Steps>
            <Unit>ML</Unit>
            <Calculation/>
          </Fluid>
          <Comments>
            <Comment Text="Infusionstid 120 minuter ska användas om tislelizumab ges i dosen 400mg vid allra första kuren."/>
            <Comment Text="Om läkemedlet givits tidigare i dosen 200mg - ge den första högre dosen  (400mg) under 90 minuter. Om det gått bra kan nästa dos 400mg ges på 60 minuter. Om även den tolereras väl kan efterföljande behandlingar ges med infusionstid 30 min."/>
          </Comments>
        </Line>
      </Lines>
    </Day>
  </Days>
</CourseDefinition>
